Clinical Trial Update: A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for neoadjuvant Endostar with chemotherapy in Stage III breast cancer across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Stage III Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN